99107-5
Stimulants drug panel - Urine by Screen method
Active
Term Description
This panel aides in the determination of compliance or identify illicit stimulant drug use. The panel detects stimulants which stimulate the central nervous system activity and, in part, suppress the appetite. Amphetamine and methamphetamine are also prescription drugs used in the treatment of narcolepsy and attention-deficit disorder/attention-deficit hyperactivity disorder (ADHD). Methylphenidate is another stimulant used to treat ADHD. Phentermine is indicated for the management of obesity. All of the other amphetamines (e.g., methylenedioxymethamphetamine: MDMA) are Drug Enforcement Administration (DEA) scheduled Class I compounds. Physiological symptoms associated with very high amounts of ingested amphetamine or methamphetamine include elevated blood pressure, dilated pupils, hyperthermia, convulsions, and acute amphetamine psychosis.
If a stimulant or its corresponding metabolite is identified (present), it indicates that the patient has used the respective stimulant in the recent past (typically 1-3 days). The absence of the expected stimulant or its metabolites may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted or adulterated urine, or limitations of testing. The concentration of the drug must be greater than or equal to the cutoff to be reported as present.
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
99107-5 | Stimulants drug panel - Urine by Screen method | |||
Indent19554-5 | Methamphetamine [Presence] in Urine by Screen method | |||
Indent19674-1 | Phentermine [Presence] in Urine by Screen method | |||
Indent19343-3 | Amphetamine [Presence] in Urine by Screen method | |||
Indent19659-2 | Phencyclidine [Presence] in Urine by Screen method | |||
Indent19577-6 | Methylphenidate [Presence] in Urine by Screen method | |||
Indent19568-5 | Methylenedioxymethamphetamine [Presence] in Urine by Screen method | |||
Indent59844-1 | Methylenedioxyethylamphetamine [Presence] in Urine by Screen method | |||
Indent19565-1 | Methylenedioxyamphetamine [Presence] in Urine by Screen method |
Fully-Specified Name
- Component
- Stimulants drug panel
- Property
- -
- Time
- Pt
- System
- Urine
- Scale
- -
- Method
- Screen
Additional Names
- Short Name
- Stimulants drug panel Ur Scn
- Display Name
- Stimulants drug panel Screen (U)
- Consumer Name Alpha Get Info
- Stimulants drug panel, Urine
Example Answer List: LL744-4
Source: Regenstrief InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 |
Basic Attributes
- Class
- PANEL.DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.72
- Last Updated
- Version 2.72
- Order vs. Observation
- Both
- Panel Type
- Panel
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Panel de drogas estimulantes: |
fr-FR | French (France) | Stimulants panel: |
it-IT | Italian (Italy) | Farmaci stimolanti, panel: Synonyms: Livelli farmacologici e tossicologia Panel farmaci stimolanti Punto nel tempo (episodio) Screening tossicologico Set di prescrizione per livelli farmacologici e to |
nl-NL | Dutch (Netherlands) | stimulerende middelen panel: Synonyms: stimulerende drugs |
zh-CN | Chinese (China) | 兴奋剂类药物组套: Synonyms: 兴奋剂类(兴奋剂、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=99107-5 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/99107-5
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright